115 related articles for article (PubMed ID: 8102290)
1. [The pharmacokinetic and biopharmaceutical evaluation of the new tranquilizer gidazepam].
Kolyvanov GB; Kruchenkov AA; Litvin AA; Zherdev VP; Otabekova SG
Eksp Klin Farmakol; 1993; 56(2):53-5. PubMed ID: 8102290
[TBL] [Abstract][Full Text] [Related]
2. [Gidazepam biotransformation and pharmacokinetics in different species of animals and man].
Kolyvanov GB; Zherdev VP; Chirkov AM; Otabekova SG; Litvin AA
Eksp Klin Farmakol; 1993; 56(3):48-50. PubMed ID: 8106054
[TBL] [Abstract][Full Text] [Related]
3. [An experimental study of the pharmacokinetic mechanisms for the development of gidazepam tolerance].
Garibova TL; Zherdev VP; Voronina TA; Kolyvanov GB; Otabekova SG
Eksp Klin Farmakol; 1993; 56(6):48-50. PubMed ID: 7906580
[TBL] [Abstract][Full Text] [Related]
4. [The pharmacokinetic aspects of the clinical action of gidazepam].
Zherdev VP; Neznamov GG; Kolyvanov GB; Litvin AA; Otabekova SG
Eksp Klin Farmakol; 1993; 56(3):50-2. PubMed ID: 8106055
[TBL] [Abstract][Full Text] [Related]
5. [The effect of pharmaceutic aids on gidazepam biotransformation and bioavailability].
Otabekova SG; Kolyvanov GB; Zherdev VP; Litvin AA; Vyrovshchikova SM
Eksp Klin Farmakol; 1993; 56(6):50-2. PubMed ID: 7906581
[TBL] [Abstract][Full Text] [Related]
6. [Biokinetics of a new prodrug gidazepam and its metabolite].
Andronati SA; Zin'kovskiĭ VG; Totrova MIu; Golovenko NIa; Stankevich EA; Zhuk OV
Biull Eksp Biol Med; 1992 Jan; 113(1):45-7. PubMed ID: 1356504
[TBL] [Abstract][Full Text] [Related]
7. Biokinetics of gidazepam, derivatives of peptideaminobenzophenones and their metabolites.
Zhuk OV; Zinkovski VG; Golovenko NY; Stankevich EA; Totrova MY
Exp Toxicol Pathol; 1999 Jul; 51(4-5):451-4. PubMed ID: 10445415
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the tranquilizer gidazepam on the behavioral reactions of rats in the first weeks after resuscitation].
Mutuskina EA; Garibova TL; Zarzhetskiĭ IuV; Maula M; Voronina TA; Gurvich AM
Patol Fiziol Eksp Ter; 1994; (3):10-2. PubMed ID: 7824332
[TBL] [Abstract][Full Text] [Related]
9. [Comparative analysis of antiarrhythmic action and electrophysiological effects of a new benzodiazepine derivative gidazepam and ethacizin in arrhythmias of various genesis].
Skibitskiĭ VV; Petrova TR; Kanorskiĭ SG
Kardiologiia; 1992 Jun; 32(6):35-7. PubMed ID: 1405290
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic modeling of ethyl loflazepate (Victan) and its main active metabolites.
Ba BB; Iliadis A; Cano JP
Ann Biomed Eng; 1989; 17(6):633-46. PubMed ID: 2574017
[TBL] [Abstract][Full Text] [Related]
11. [New pharmacodynamic effects of gidazepam and befol in patients with cardiac arrhythmias].
Skibitskiĭ VV; Kanorskiĭ SG
Eksp Klin Farmakol; 1993; 56(5):23-7. PubMed ID: 7906171
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
[TBL] [Abstract][Full Text] [Related]
13. [The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level].
Neznamov GG; Morozov IS; Barchukov VG; Teleshova ES; Siuniakov SA; Zhirov EN; Tkachev AE; Belyĭ IuN; Kolotilinskaia NV; Safarova TP; Barannikov AS; Chernyĭ AV; Shestopalov SS
Eksp Klin Farmakol; 1997; 60(4):17-21. PubMed ID: 9376749
[TBL] [Abstract][Full Text] [Related]
14. [The pharmacokinetic characteristics of fenazepam in epileptics].
Maksutova EL; Sariev AK; Zherdev VP; Voronina TA; Zheleznova EV
Eksp Klin Farmakol; 1994; 57(2):16-8. PubMed ID: 7911365
[TBL] [Abstract][Full Text] [Related]
15. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
Chen IW; Lin JH
Drug Metab Dispos; 1994; 22(5):693-9. PubMed ID: 7835219
[TBL] [Abstract][Full Text] [Related]
16. [The behavioral characteristics of young and sexually mature animals administered fenazepam, gidazepam and medazepam].
Voronina TA; Molodavkin GM; Ramkhin EIa
Eksp Klin Farmakol; 1993; 56(3):3-5. PubMed ID: 8106053
[TBL] [Abstract][Full Text] [Related]
17. New approach in bioavailability study of two formulations of ethyl loflazepate.
Ba BB; Iliadis A; Durand A; Berger Y; Cano JP
Arzneimittelforschung; 1988 Oct; 38(10):1486-9. PubMed ID: 2904268
[TBL] [Abstract][Full Text] [Related]
18. [The effect of gidazepam on the cardiovascular system function in patients with neurotic reactions and in healthy subjects under aggravated conditions].
Morozov IS; Barchukov VG; Neznamov GG
Eksp Klin Farmakol; 1998; 61(1):30-2. PubMed ID: 9575408
[TBL] [Abstract][Full Text] [Related]
19. [Simulation of kinetics of phenazepam and its metabolite 3-hydroxyphenazepam in cat blood].
Zherdev VP; Ekonomov AL; Brestkina LM; Janku I; Havlik I
Biull Eksp Biol Med; 1982 Oct; 94(10):54-6. PubMed ID: 7171799
[TBL] [Abstract][Full Text] [Related]
20. Quazepam: hypnotic efficacy and side effects.
Kales A
Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
